# Coala Life

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/coala-life

- Industry: Medical Devices & Equipment
- Headquarters: Stockholm, Sweden
- Website: www.coalalife.com
- Total disclosed funding: $9.7M
- Latest round: Series A (Apr 24, 2019)
- Investors on record: 1

## About

Coala Life AB is a healthcare technology company specializing in innovative remote monitoring solutions for cardiovascular health, enabling patients and professionals to monitor ECG and heart sounds efficiently.Founded in 2014 in Stockholm, Sweden, Coala Life AB develops advanced cardiac monitoring systems. The company's founders, Magnus Samuelsson and Ulf Tossman, have a background in technology and business. Since its inception, Coala Life has successfully raised SEK 92 million in Series A funding from 20 North Street and other investors, with the most recent deal occurring on April 24, 2019. The company has completed a total of 5 deals to date.Coala Life AB offers the Coala Heart Monitor System, which integrates a monitoring device and mobile application for ECG and heart sound measurements. This platform allows patients to take chest and thumb ECG measurements independently, with real-time algorithm-based interpretations accessible to both patients and healthcare providers. The Coala Care portal enables healthcare professionals to review these measurements, streamlining patient care and reducing administrative tasks. Target markets include Europe and North America, responding to the growing demand for remote healthcare solutions.In the most recent fiscal year 2022, Coala Life generated revenue of SEK 326,242.50 and reported an EBITDA of SEK -10,651,103.20. The company operates on a pay-per-use model, facilitating easy prescription of monitoring solutions by healthcare providers without upfront costs. Partnerships with healthcare facilities drive revenue generation, with monitoring devices dispatched directly to patients following diagnosis.Coala Life AB aims to expand its product offerings and enhance its presence in new markets. The company is focused on developing additional monitoring devices that will be launched in the coming years. The SEK 92 million raised in Series A funding will support these initiatives, with plans to penetrate markets in Asia and other regions by 2025. The funding will also bolster ongoing development and marketing efforts for its flagship products.

## Funding rounds

- Series A, Apr 24, 2019, $9.7M — 20 North Street

## Investors

- 20 North Street (https://capitalatlas.ai/funds/20-north-street) — Series A